Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects

Clinical trial NCT00262522 · COMPLETED

Trial details

NCT number: NCT00262522
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Infections

Start date: 2005-11-01
Primary completion: 2008-07-01
Enrollment: 664

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.